Objective: The objective of our study is to determine if human immunodeficiency virus (HIV)-positive pregnant patients have a higher rate of group B streptococcus (GBS) rectovaginal colonization compared with HIV-negative pregnant patients.

Study Design: Our study is a multi-site retrospective study performed at Ochsner Louisiana State University-Health Shreveport and Monroe campuses including patients who delivered between December 2011and June 2019. Rates of GBS rectovaginal colonization between HIV-positive pregnant patients were compared with a control group of HIV-negative patients. The control group was age and race matched in a 2:1 fashion. The primary outcome was to investigate rates of GBS rectovaginal colonization. Secondary outcomes included GBS culture antibiotic sensitivities, presence of GBS urinary tract infection, GBS positivity based on HIV viral load, and GBS positivity based on new vs established diagnosis of HIV. Continuous data were analyzed using an unpaired -test, and categorical data were analyzed using a Chi-squared test. The probability level of <0.05 was set as statistically significant.

Results: A total of 225 patients were included in the final analysis, 75 HIV-positive and 150 HIV-negative controls. Demographic differences were noted. HIV-positive patients were more likely to deliver preterm and were more likely to deliver via cesarean section. Our primary outcome showed no significant differences in incidence of GBS colonization between HIV-positive patients and control group ( = 31, 41.3% vs  = 46, 30.6%,  = 0.136). Antibiotic resistance patterns showed no significant difference between the two groups. There were no significant differences in GBS positivity based on HIV viral load.

Conclusion: Our study does not show a statistically significant difference in the incidence of GBS colonization between HIV-positive patients and HIV-negative controls.

Key Points: · HIV-positive pregnant patients do not have an increased risk of GBS rectovaginal colonization.. · HIV-positive pregnant patients have similar rates of GBS colonization regardless of viral load.. · GBS antibiotic sensitivities are similar in HIV-positive and HIV-negative pregnant patients..

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0041-1739356DOI Listing

Publication Analysis

Top Keywords

rectovaginal colonization
16
pregnant patients
12
gbs rectovaginal
12
group streptococcus
8
compared hiv-negative
8
hiv-negative pregnant
8
hiv-positive pregnant
8
rates gbs
8
control group
8
gbs positivity
8

Similar Publications

Background: Group B streptococcus (GBS) colonization in pregnant women is associated with adverse perinatal outcomes, including stillbirth. This meta-analysis investigated the relationship between maternal rectovaginal GBS colonization and the risk of stillbirth.

Methods: We conducted a comprehensive literature search across several databases, including PubMed, Embase, Web of Science, Wanfang, and China National Knowledge Infrastructure, covering studies published from the inception of the database until September 9, 2024.

View Article and Find Full Text PDF

Maternal Colonization of Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae in Preterm Rupture of Membranes.

J Obstet Gynaecol Can

December 2024

Department of Obstetrics and Gynecology, Galilee Medical Center, Nahariya, Israel; Azrieli Faculty of Medicine, Bar Ilan University, Safed, Israel.

Objectives: Maternal colonization by extended-spectrum β-lactamase-producing Enterobacteriaceae (ESBL-E) has risen, and the antimicrobial resistance of ESBL-E is significant. We aimed to evaluate the rates of ESBL-E colonization among women with preterm premature rupture of membranes (PPROM) and of maternal-neonatal vertical transmission. We also aimed to compare obstetrical and neonatal complications among ESBL-E positive versus negative maternal colonization in pregnancies complicated by PPROM.

View Article and Find Full Text PDF

Group B streptococcal infections in pregnancy and early life.

Clin Microbiol Rev

November 2024

Department of Obstetrics & Gynecology, University of Washington, Seattle, Washington, USA.

SUMMARYBacterial infections with Group B (GBS) are an important cause of adverse outcomes in pregnant individuals, neonates, and infants. GBS is a common commensal in the genitourinary and gastrointestinal tracts and can be detected in the vagina of approximately 20% of women globally. GBS can infect the fetus either during pregnancy or vaginal delivery resulting in preterm birth, stillbirth, or early-onset neonatal disease (EOD) in the first week of life.

View Article and Find Full Text PDF

Introduction: Neonatal infections can rapidly become severe, with delays in treatment often proving fatal. (Group B , GBS) is a common cause, typically transmitted from colonized pregnant women to neonates during childbirth. In Vietnam, routine prenatal care lacks standardized GBS screening protocols.

View Article and Find Full Text PDF
Article Synopsis
  • The study focused on Group B Streptococci (GBS), a significant risk for neonatal infections, examining its prevalence and antibiotic resistance in pregnant women in Nigeria.
  • In 87 pregnant women, the prevalence of GBS colonization was found to be 43.6%, with a notably high resistance to erythromycin and vancomycin at 48.2% and 66.4%, respectively.
  • The majority of GBS isolates were strong biofilm producers and there was a high rate of multidrug resistance (MDR) detected, highlighting the need for testing antibiotic susceptibilities in pregnant women to improve treatment and reduce newborn infections.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!